hotspot -WSS

hotspot

author：fashion 2025-10-02 23:30:53 - browse：27599

A display of TVs against an orange background. -- health policy coverage from STAT — Adobe

WASHINGTON — Government regulators may soon decide whether to crack down on distracting visuals in television drug commercials or require subtitles about side effects, a regulation that’s been 13 years in the making.

White House budget experts are reviewing changes to the regulation of broadcast drug advertisements that the Food and Drug Administration proposed in 2010, according to the Office of Management and Budget website. That proposal aimed to make commercials present drug risks in a manner that consumers notice and understand.

Drug ads have long been controversial. Aside from New Zealand, the United States is the only country that allows drug makers to advertise to consumers. Critics of drug ads say they pose consumer safety concerns by bombarding the public with promotions that distract viewers from potential side effects. Drug companies say commercials spark conversations between patients and doctors that promote clinically beneficial prescribing.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Bispecific antibodies are next new thing in cancer immunotherapy

entertainment

WSS

Biden administration plans revamp of organ transplant system

Can medical device makers keep up in the race to treat obesity?

How state and local governments are sidelining science

How state and local governments are sidelining science

Mom launches Girl Scout troop for LGBTQ youth in Texas

Altering the blood type of lungs raises potential for universal organs for transplants

Wikipedia

hotspot

entertainment

State Dept. review finds Biden bears some blame for Afghanistan failures

What health policies could hitch a ride on a spending bill?

23andMe had bad news about my health. I wish a person had delivered it

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

United colonoscopy coverage change 'may cost lives,' doctors say

UnitedHealth sued over use of algorithm in Medicare Advantage plans

Medicare details structure of new drug price negotiation program

NIH chief: government has fallen behind pharma on clinical trials

Affirmative action in medical school literally saved lives

Eli Lilly’s Mounjaro succeeds in second weight

explore

White House drug czar issues call for 'recovery

FDA approves first new drug developed for postpartum depression

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Carbon Health diabetes program, a test of data

Medical school prerequisites are outdated

Type 2 diabetes prevention programs work at large scale: study

hotspot

entertainment

hotspot

entertainment